ARQT
NASDAQStockArcutis Biotherapeutics, Inc.
$22.70-0.20 (-0.89%)
52-Week Range
$12.59
$31.20
Key Stats
Market Cap
2.8B
P/E Ratio
—
Dividend Yield
—
Beta
1.74
Volume
597.4K
Avg Volume
1.6M
Performance
1M
-14.23%
3M
-20.86%
6M
+35.32%
YTD
-21.00%
1Y
+56.70%
3Y
+106.21%
5Y
-29.59%
Price Chart
ETF Exposure
ARQT is held by 107 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| DX2D.DE | Xtrackers LPX Private Equity Swap UCITS ETF 1C | 5.00% |
| GURU | Global X - Guru Index ETF | 1.31% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 1.27% |
| BBP | Virtus Biotech ETF | 1.26% |
| CURE.AX | Global X - S&P Biotech ETF | 0.86% |
| XBI | State Street SPDR S&P Biotech ETF | 0.86% |
| AFSM | First Trust Active Factor Small Cap ETF | 0.55% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.52% |
| HELX | Franklin Genomic Advancements ETF | 0.46% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.36% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.33% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.25% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.25% |
| IBB | iShares Biotechnology ETF | 0.23% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.22% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.22% |
| PSC | Principal U.S. Small-Cap Multi-Factor ETF | 0.21% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.21% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.19% |
| PWS | Pacer WealthShield ETF | 0.19% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.17% |
| IWO | iShares Russell 2000 Growth ETF | 0.17% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.16% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.16% |
| ISMD | Inspire Small/Mid Cap ETF | 0.15% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.15% |
| STXK | Strive Small-Cap ETF | 0.13% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.12% |
| FSML | Franklin Small Cap Enhanced ETF | 0.12% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.12% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.12% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.10% |
| RSSL | Global X - Russell 2000 ETF | 0.10% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.09% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.09% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.09% |
| VTWO | Vanguard Russell 2000 ETF | 0.09% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.09% |
| IWM | iShares Russell 2000 ETF | 0.09% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.09% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.09% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.09% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.08% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.08% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.07% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.07% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.06% |
| UWM | ProShares - Ultra Russell2000 | 0.06% |
| CUS1.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.06% |
| CUSS.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.06% |
Page 1 of 3Next
About ARQT ETF Exposure
Arcutis Biotherapeutics, Inc. (ARQT) is held by 107 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.8B, ARQT is a widely held institutional stock. The stock currently trades at $22.70. Investors can gain exposure to ARQT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ARQT, sorted by portfolio weight.